MSD has kicked off a new phase 3 trial of its oral LSD1 inhibitor bomedemstat in essential thrombocythaemia (ET), one of a rare type of blood cancer known as myeloproliferative neoplasms (MPNs). The ...
As 2025 unfolded, returning to the ritual of asking filmmakers about the films that moved them feels both fragile and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback